These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27582881)

  • 1. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial.
    Mousa N; Abdel-Razik A; Zaher A; Hamed M; Shiha G; Effat N; Elbaz S; Elhelaly R; Hafez M; El-Wakeel N; Eldars W
    Therap Adv Gastroenterol; 2016 Sep; 9(5):684-91. PubMed ID: 27582881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial).
    Janyajirawong R; Vilaichone RK; Sethasine S
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2879-2887. PubMed ID: 34582657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver.
    Bale A; Pai CG; Shetty S; Balaraju G; Shetty A
    J Clin Exp Hepatol; 2018 Jun; 8(2):156-161. PubMed ID: 29892178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial.
    Pratap Mouli V; Benjamin J; Bhushan Singh M; Mani K; Garg SK; Saraya A; Joshi YK
    Hepatol Res; 2015 Aug; 45(8):880-9. PubMed ID: 25266207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P; Sharma BC
    Saudi J Gastroenterol; 2012; 18(3):168-72. PubMed ID: 22626795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age-and, education-corrected number connection test and digit symbol test in diagnosis of minimal hepatic encephalopathy].
    Hao L; Hu Y; Hou X
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jul; 23(7):533-7. PubMed ID: 26398846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
    Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
    Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese herbal medicine formula Jieduhuayu granules improves cognitive and neurophysiological functions in patients with cirrhosis who have minimal hepatic encephalopathy: a randomized controlled trial.
    Yao C; Huang G; Wang M; Xia M; Yao F; Niu D; Zhang Y; Li S; Zhong Y
    Complement Ther Med; 2014 Dec; 22(6):977-85. PubMed ID: 25453517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study.
    Rathi S; Chopra M; Chouduri G; Sharma P; Madan K; Chhabra M; Rai RR; Govil A; Konar A; Goenka M; Agarwal M; Mukherjee J; Thorat V; Salunkhe S; Abraham P; Nagral A; Jhaveri A; Bhat N; Varghese J; R S A; Ravishankar ; Reddy DC; Dhiman RK
    J Clin Exp Hepatol; 2019; 9(4):476-483. PubMed ID: 31516264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotic yogurt for the treatment of minimal hepatic encephalopathy.
    Bajaj JS; Saeian K; Christensen KM; Hafeezullah M; Varma RR; Franco J; Pleuss JA; Krakower G; Hoffmann RG; Binion DG
    Am J Gastroenterol; 2008 Jul; 103(7):1707-15. PubMed ID: 18691193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.
    Zhang Y; Feng Y; Cao B; Tian Q
    Int J Clin Exp Med; 2015; 8(2):2954-7. PubMed ID: 25932262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.